Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

The European Commission has chosen to expand the authorised indication for Amgen’s Blincyto (blinatumomab) in the region, it has emerged, approving...
Samsung Bioepis’ has announced that the FDA has chosen to approve Ontruzant (trastuzumab-dttb), its biosimilar version of Roche’s Herceptin (...
The European Commission has decided to approve a label extension in the region for Orkambi in the treatment of cystic fibrosis (CF), expanding the...
Clinical trials have led to nearly 5,000 deaths in India since 2005, while just a fraction of those affected have received compensation.
Eli Lilly's Lartruvo failed to present clinical benefit in the treatment of advanced or metastatic soft tissue sarcoma (STS) when used in...
New Jersey-based biotechnology firm Celgene has signed deals with two Massachusetts-based biotechs: immuno-oncology specialist Kyn therapeutics and...
Sir Philip Hampton is stepping down from his role as non-executive chairman of British multinational GlaxoSmithKline. The resignation comes just...
Braftovi (encorafenib), a BRAF kinase inhibitor developed by Pierre Fabre, has been awarded approval by UK drug watchdog NICE for the treatment of...
Top ten stories on Pharmafile.com this week!
A new recommendation from NICE means that thousands of patients in England and Wales will be able to receive Abbvie’s Venclyxto (venetoclax) in...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches